BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:03 PM
Apr 03, 2009
 |  BC Extra  |  Top Story

Arzerra gets Priority Review

Genmab A/S (CSE:GEN) said FDA accepted and granted Priority Review to a BLA for Arzerra ofatumumab to...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >